TY - JOUR
T1 - Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure–activity relationship study of 4-epi-jaspine B
AU - Ohno, Hiroaki
AU - Honda, Maho
AU - Hamada, Naoka
AU - Miyagaki, Jun
AU - Iwata, Akira
AU - Otsuki, Kazuhiro
AU - Maruyama, Toru
AU - Nakamura, Shinya
AU - Nakanishi, Isao
AU - Inuki, Shinsuke
AU - Fujii, Nobutaka
AU - Oishi, Shinya
N1 - Funding Information:
This work was supported by the JSPS KAKENHI (Grant Numbers JP15KT0061 and JP15H04654), the Uehara Memorial Foundation, Japan, and the Platform for Drug Design, Discovery and Development from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.
Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017
Y1 - 2017
N2 - We recently reported that 4-epi-jaspine B exhibits potent inhibitory activity towards sphingosine kinases (SphKs). In this study, we investigated the effects of modifying the 2-alkyl group, as well as the functional groups on the THF ring of 4-epi-jaspine B using a diversity-oriented synthesis approach based on a late-stage cross metathesis reaction. The introduction of a p-phenylene tether to the alkyl group was favored in most cases, whereas the replacement of a carbon atom with an oxygen atom led to a decrease in the inhibitory activity. Furthermore, the introduction of a bulky alkyl group at the terminus led to a slight increase in the inhibitory activity of this series towards SphKs compared with 4-epi-jaspine B (the Q values of compound 13 for SphK1 and SphK2 were 0.2 and 0.4, respectively). Based on this study, we identified two isoform selective inhibitors, including the m-phenylene derivative 4 [IC50 (SphK1) ≥30 μM; IC50 (SphK2) = 2.2 μM] and the methyl ether derivative 22 [IC50 (SphK1) = 4.0 μM; IC50 (SphK2) ≥30 μM].
AB - We recently reported that 4-epi-jaspine B exhibits potent inhibitory activity towards sphingosine kinases (SphKs). In this study, we investigated the effects of modifying the 2-alkyl group, as well as the functional groups on the THF ring of 4-epi-jaspine B using a diversity-oriented synthesis approach based on a late-stage cross metathesis reaction. The introduction of a p-phenylene tether to the alkyl group was favored in most cases, whereas the replacement of a carbon atom with an oxygen atom led to a decrease in the inhibitory activity. Furthermore, the introduction of a bulky alkyl group at the terminus led to a slight increase in the inhibitory activity of this series towards SphKs compared with 4-epi-jaspine B (the Q values of compound 13 for SphK1 and SphK2 were 0.2 and 0.4, respectively). Based on this study, we identified two isoform selective inhibitors, including the m-phenylene derivative 4 [IC50 (SphK1) ≥30 μM; IC50 (SphK2) = 2.2 μM] and the methyl ether derivative 22 [IC50 (SphK1) = 4.0 μM; IC50 (SphK2) ≥30 μM].
KW - Jaspine B
KW - Kinase inhibitor
KW - Sphingosine kinase
KW - Structure–activity relationship
UR - http://www.scopus.com/inward/record.url?scp=85017379147&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85017379147&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2017.03.059
DO - 10.1016/j.bmc.2017.03.059
M3 - Article
C2 - 28408190
AN - SCOPUS:85017379147
SN - 0968-0896
VL - 25
SP - 3046
EP - 3052
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 12
ER -